EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy

Hiba-Allah Chatti, Ibtissem Oueslati iD, Aymen Azaiez, Jihen Marrakchi, Seif Boukriba, Habiba Mizouni, Slim Haouet, Ghazi Besbes, Meriem Yazidi iD, Melika Chihaoui

Endocrinology, Diabetes & Metabolism · 2023-07 · 6 (4)

DOI: 10.1002/edm2.434 ↗

At a glance

Journal article in Endocrinology, Diabetes & Metabolism, published online on 2023-06-16. Written by Hiba-Allah Chatti and 9 co-authors. Institution: Department of Endocrinology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia. Major MEDLINE topics: Thyroid Nodule, Thyroid Neoplasms. Cited 7 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Several ultrasound scoring systems have been developed to stratify the risk of malignancy of thyroid nodules, including ACR (American College of Radiology) and EU (European) TI‐RADS. This study aimed to assess the diagnostic performance of these two classifications using histology as a reference standard.

Methods

It was a single‐centre, retrospective study including 156 patients who underwent thyroidectomy. Ultrasound data of 198 nodules (99 malignant nodules and 99 benign nodules) were analysed. Both classifications were applied for all nodules.

Results

Ultrasound criteria associated with malignancy were solid composition (OR=7.81; p < 10 −3 ), hypoechoic character (OR=16.42; p < 10 −3 ), irregular contours (OR=7.47; p < 10 −3 ), taller‐than‐wide shape (OR=3.58; p = 0.02), microcalcifications (OR=3.02; p = .006) and the presence of cervical adenopathy (OR=3.89; p = .006). The prevalence of malignancy was 15.5%, 69% and 76.9% for EU TI‐RADS categories 3, 4 and 5, respectively. It was 33.3%, 57% and 91.1% for ACR TI‐RADS categories 3, 4 and 5, respectively. For category 5, EU TI‐RADS and ACR TI‐RADS had sensitivities of 60% and 41%, specificities of 82% and 96%, respectively. For categories 4 and 5 combined, the diagnostic performance of these two classification systems became comparable with a sensitivity of 89% and 86% for EU‐TIRADS and ACR‐TIRADS, respectively. The area under the ROC curve was 0.81 for the EU TI‐RADS classification and 0.82 for the ACR TI‐RADS classification.

Conclusions

EU TI‐RADS and ACR TI‐RADS scoring systems seem to be comparable in predicting malignancy in thyroid nodules.

Subjects

MeSH terms (MEDLINE)

Thyroid NoduleThyroid NeoplasmsHumansRetrospective StudiesUltrasonography

Author keywords

diagnostic imagingmalignancy riskthyroid carcinomathyroid noduleultrasound classifications

Authors and institutions

  • Department of Endocrinology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
  • Department of Oto-Rhino-laryngology, La Rabta university Hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
  • Department of Radiology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
  • Department of Pathology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.

ORCID profiles: Ibtissem Oueslati, Meriem Yazidi

Cite

APA

Chatti, H. A., Oueslati, I., Azaiez, A., Marrakchi, J., Boukriba, S., Mizouni, H., Haouet, S., Besbes, G., Yazidi, M., & Chihaoui, M. (2023). Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy. Endocrinology, Diabetes & Metabolism, 6(4). https://doi.org/10.1002/edm2.434

Vancouver

Chatti HA, Oueslati I, Azaiez A, Marrakchi J, Boukriba S, Mizouni H, et al. Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy. Endocrinology, Diabetes & Metabolism. 2023;6(4). doi:10.1002/edm2.434

BibTeX
@article{Chatti2023,
  author = {Chatti, Hiba-Allah and Oueslati, Ibtissem and Azaiez, Aymen and Marrakchi, Jihen and Boukriba, Seif and Mizouni, Habiba and Haouet, Slim and Besbes, Ghazi and Yazidi, Meriem and Chihaoui, Melika},
  title = {Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2023},
  volume = {6},
  number = {4},
  doi = {10.1002/edm2.434}
}
Start for free →